|
| |
Innogenetics NVInnogenetics NV is an international biotechnology company that develops and markets diagnostic products to improve therapy management and patient health.
Innogenetics develops and markets a range of diagnostic assays with a focus on molecular diagnostics and multiparameter testing. Its products are sold in over 90 countries through its 6 subsidiaries and a large number of distributors. In 2007, Diagnostics sales totalled EUR 47.0 million, more than 95% of which were achieved outside Belgium.
Innogenetics is a Solvay Pharmaceuticals company. Solvay Pharmaceuticals is the global pharmaceuticals sector of the Solvay Group.
Innogenetics is no longer listed on NYSE Euronext Brussels.
| Contact Details: |
| Technologie park Zwijnaarde 6 |
| Ghent |
| |
| B-9052 |
| Belgium |
| Tel: | 329 329 1724 |
| Fax: | 329 329 7625 |
| Email: | |
| WWW: | www.innogenetics.com/
|
| |
Recent Publications by Innogenetics NV: |  |
Evolution of primary and compensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during long-term lamivudine treatment, assessed by a line probe assay.
With the availability of more potent nucleotide/nucleoside analogues, the... | 18th January, 2008
| Innogenetics NV, Industriepark Zwijnaarde 7/4, B-9052, Ghent, Belgium.
| J Clin Microbiol. 2007 Dec;45(12):3935-41. Epub 2007 Oct 3.
DOI Direct Link |
Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.
Protein sequences from multiple hepatitis B virus (HBV) isolates were... | 11th January, 2008
| GENimmune NV (Innogenetics NV), Ghent, Belgium.
| J Virol. 2008 Jan;82(1):435-50. Epub 2007 Oct 17.
DOI Direct Link |
Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies.
BACKGROUND: Total tau (T-tau) and beta-amyloid((1-42)) (Abeta(1-42))... | 27th February, 2007
| Innogenetics NV, Industriepark Zwijnaarde 7, 9052 Gent, Belgium.
| Clin Chem Lab Med. 2006;44(12):1472-80.
DOI Direct Link |
Role of mannose-binding lectin (MBL2) genotyping in predicting the risk of recurrent otitis media (rOM).
Nucleic acid-based diagnostics gradually are replacing or complementing... | 6th February, 2007
| Innogenetics NV, Ghent, Belgium.
| Adv Exp Med Biol. 2006;586:281-90.
DOI Direct Link |
A review of current and future molecular diagnostic tests for use in the microbiology laboratory.
Nucleic acid-based diagnostics gradually are replacing or complementing... | 27th October, 2006
| Microbiology Unit, R&D Diagnostics, INNOGENETICS NV, Gent, Belgium.
| Methods Mol Biol. 2006;345:1-21.
DOI Direct Link |
→View more Innogenetics NV research publications. |
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 489 times since April 2007, the link to the organisation's website has been followed 74 times Recent Search Terms used to find this page: Innogenetics contact number | innogenetics nv belgium | innogenetics logo | innogenetics nv belgium | Innogenetics N.V. gent | Innogenetics 9052 | innogenetics nv belgium | innogenetics zwijnaarde | INNOGENETICS NV GHENT BELGIUM | INNOGENETICS NV GHENT BELGIUM | . Search for more companies in Ghent Search for more companies in This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Innogenetics NV |
